Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Samuel

Showing results (281-290 of 451) with videos related to

Pageof 46
Sort By:
Hepatobiliary Surgery and Nutrition|November 11, 2021
Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-upNada El-Domiaty, Faouzi Saliba, Vincent Karam, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2011
Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trialLutz Fischer, Pavel Trunečka, Bruno Gridelli, et al.
AIDS (London, England)|May 7, 2009
Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicityMariagrazia Tateo, Anne-Marie Roque-Afonso, Teresa Maria Antonini, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrenceAudrey Coilly, Valérie Furlan, Bruno Roche, et al.
Alimentary Pharmacology & Therapeutics|May 31, 2025
Underdiagnosis of Alpha-1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective StudyManon Evain, Isaac Ruiz, Teresa Antonini, et al.
Communications Biology|July 25, 2022
PI3Kδ activity controls plasticity and discriminates between EMT and stemness based on distinct TGFβ signalingJean Agnetti, Vanessa Bou Malham, Christophe Desterke, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BBHermann E Wasmuth, Carmen G Tag, Eddie Van de Leur, et al.
Annals of Surgery|December 10, 2015
Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?Prashant Bhangui, Marc Antoine Allard, Eric Vibert, et al.
Cancer Research|September 11, 2012
Iodide transporter NIS regulates cancer cell motility and invasiveness by interacting with the Rho guanine nucleotide exchange factor LARGClaire Lacoste, Julie Hervé, Myriam Bou Nader, et al.
Oncotarget|September 17, 2017
Hepatitis C virus core protein targets 4E-BP1 expression and phosphorylation and potentiates Myc-induced liver carcinogenesis in transgenic miceCosette Abdallah, Charlène Lejamtel, Nassima Benzoubir, et al.
Pageof 46

Showing results (281-290 of 451) with videos related to

Sort By:
Pageof 46
Hepatobiliary Surgery and Nutrition|November 11, 2021
Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-upNada El-Domiaty, Faouzi Saliba, Vincent Karam, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2011
Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trialLutz Fischer, Pavel Trunečka, Bruno Gridelli, et al.
AIDS (London, England)|May 7, 2009
Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicityMariagrazia Tateo, Anne-Marie Roque-Afonso, Teresa Maria Antonini, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrenceAudrey Coilly, Valérie Furlan, Bruno Roche, et al.
Alimentary Pharmacology & Therapeutics|May 31, 2025
Underdiagnosis of Alpha-1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective StudyManon Evain, Isaac Ruiz, Teresa Antonini, et al.
Communications Biology|July 25, 2022
PI3Kδ activity controls plasticity and discriminates between EMT and stemness based on distinct TGFβ signalingJean Agnetti, Vanessa Bou Malham, Christophe Desterke, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BBHermann E Wasmuth, Carmen G Tag, Eddie Van de Leur, et al.
Annals of Surgery|December 10, 2015
Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?Prashant Bhangui, Marc Antoine Allard, Eric Vibert, et al.
Cancer Research|September 11, 2012
Iodide transporter NIS regulates cancer cell motility and invasiveness by interacting with the Rho guanine nucleotide exchange factor LARGClaire Lacoste, Julie Hervé, Myriam Bou Nader, et al.
Oncotarget|September 17, 2017
Hepatitis C virus core protein targets 4E-BP1 expression and phosphorylation and potentiates Myc-induced liver carcinogenesis in transgenic miceCosette Abdallah, Charlène Lejamtel, Nassima Benzoubir, et al.
Pageof 46